Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-02-04
1994-10-11
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 851, 424499, A61K 3724, A61K 912
Patent
active
053549341
ABSTRACT:
Erythropoietin (EPO) can be delivered systemically in therapeutically or prophylactically effective amounts by pulmonary administration using a variety of pulmonary delivery devices, including nebulizers, metered dose inhalers and powder inhalers. Aerosol administration of EPO in accordance with this invention results in significant elevation of red blood cell levels. EPO can be administered in this manner to medically treat or prevent anemia, as well as to treat or prevent other maladies related to erythropoiesis.
REFERENCES:
patent: 4635627 (1987-01-01), Gam
patent: 4703008 (1987-10-01), Lin et al.
patent: 5011678 (1991-04-01), Wang et al.
patent: 5013718 (1991-05-01), Adamson et al.
Patton, J. S., et al. (1992) Adv. Drug Deliv. Rev. 8: 179-96.
Hubbard, R. C., et al. (1989) Proc. Natl. Acad. Sci. USA 86: 680-84.
Peptide and Protein Drug Delivery, ed. V. Lee, Marcel Dekker, N.Y., 1990, pp. 1-11.
Adjei et al., Pharmaceutical Research, vol. 7, No. 6, pp. 565-569 (1990).
Hubbard et al., Annals of Internal Medicine, vol. 111, No. 3, pp. 206-212 (1989).
Smith et al., J. Clin. Invest., vol. 84, pp. 1145-1154 (1989).
Barrowcliffe et al., Thorax, vol. 41/2, pp. 88-93.
Debs et al., The Journal of Immunology, vol. 140, pp. 3482-3488 (1988).
Newman et al., (1983) Thorax, vol. 38, pp. 881-886.
Braquet et al., (1989) J. Cardiovascular Pharmacology, vol. 13, supp. 5, pp. 143-146.
Pitt Colin G.
Platz Robert M.
Amgen Inc.
Chambers Daniel M.
Fitzgerald David L.
Hill Jr. Robert J.
Levy Ron K.
LandOfFree
Pulmonary administration of erythropoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pulmonary administration of erythropoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pulmonary administration of erythropoietin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1660198